Food
Commented by Stefan Feulner on July 30th, 2025 | 07:30 CEST
AMD, Veganz Group, and Heidelberger Druckmaschinen AG on a roll
The current trading week promises pure excitement and could bring a surprise or two. In the coming days, nearly 40% of S&P companies will report on their second-quarter performance. Figures from heavyweights such as Microsoft, Meta Platforms, Visa, Apple, and Amazon are likely to keep the markets on their toes. Outside of the flood of figures, several companies shone with outstanding announcements, which investors rewarded with additional purchases.
Read
Commented by Fabian Lorenz on July 29th, 2025 | 07:00 CEST
YIELD MONSTERS 2025: Hensoldt, Steyr Motors, Veganz shares – another 250% gain?
When it comes to German return monsters for 2025, investors rightly think primarily of defense companies like Rheinmetall, RENK, Hensoldt, and Steyr Motors. However, with a 250% gain, the Veganz Group may well be the surprise of the year. The Company is currently reinventing itself and attacking a billion-dollar market. Analyst estimates appear to be far too conservative and are likely to be revised upward soon. The stock, therefore, remains very attractive. Hensoldt has multiplied in value in recent years and is now supplying radar systems for the protection of Ukraine. The order volume is in the mid-three-digit million range. Steyr Motors will have to grow to this revenue range in the coming years to justify its current valuation. Analysts nevertheless recommend buying the stock.
Read
Commented by Nico Popp on July 21st, 2025 | 07:15 CEST
A turning point in German healthcare! Are we moving closer to the US model? PanGenomic Health, Bayer, and Nestlé
Are US-style conditions soon coming to Germany? Health economist Jürgen Wasem is calling for greater patient cost-sharing. Certain medications could be made available over the counter, allowing patients to access them more easily at their own expense. This could help reduce costs. This form of self-medication has long been common in the US, where people with certain ailments naturally turn to over-the-counter preparations or potent health foods. How can investors benefit from this trend? We present the shares of Bayer, Nestlé, and PanGenomic Health!
Read
Commented by Juliane Zielonka on October 25th, 2024 | 07:00 CEST
Altech Advanced Materials, McDonald's, Volkswagen - Innovation and crisis resilience open up lucrative investment opportunities
In the current economic situation, investors are presented with promising opportunities in companies that stand out due to their innovative strength and skilful crisis management. Particularly attractive are companies that invest countercyclically in research and development and thus emerge from crises stronger than before. Altech Advanced Materials, with its innovative battery technology, shows how companies can tap into new market opportunities through research and development. McDonald's, on the other hand, is struggling with a food safety issue that requires rapid crisis management to restore consumer confidence. Volkswagen has to deal with the consequences of a personnel scandal in its most important foreign market, China. We take a look at the details.
Read
Commented by Fabian Lorenz on October 3rd, 2024 | 14:05 CEST
100% with HelloFresh! Are Bayer and dynaCERT taking off next?
Since the low in June, the HelloFresh share has roughly doubled. Not bad for an MDAX-listed stock with a market capitalization of EUR 1.6 billion. Can it continue at this pace, or would it be better to take profits? Analysts weigh in with their assessment. dynaCERT shows great potential. With a new German CEO, the Canadian company aims to make diesel engines more efficient and low-emission in Europe. And what is Bayer doing? Will the positive news flow help it to break out of the consolidation?
Read
Commented by Juliane Zielonka on April 26th, 2024 | 07:00 CEST
HelloFresh, First Hydrogen, Amazon: Growth in the Courier, Express, and Parcel industry
The courier, express, and parcel industry (CEP) is a true growth engine. CEP companies currently employ almost 260,000 people, more than 50% more than ten years ago. Consumers worldwide are increasingly opting for direct deliveries to their homes, whether for food or retail orders. The food company HelloFresh is benefiting from this. The figures from the first quarter of 2024 impress analysts and investors alike. Increasing delivery traffic in cities needs new solutions. This is where First Hydrogen comes into play. The Company focuses on hydrogen-powered commercial vehicles for urban deliveries. The advantage of First Hydrogen's vans is their unbeatable range of over 600 km with just a single refueling. Amazon is also scaling up its food delivery services. In the US, they are enticing Prime subscribers to take advantage of delivery benefits for groceries. This is not at all popular in Europe and violates many consumer laws. We provide the details.
Read
Commented by Fabian Lorenz on April 3rd, 2024 | 07:35 CEST
HelloFresh about to be taken over? Bayer for the anti-cyclical investor! Altech Advanced Materials convinces: Opportunities with turnaround stocks!
Bayer shares gained around 7% last week. Is this the turnaround after the stock reached a multi-year low? The Altech Advanced Materials share is also working on an upward trend. The German battery hopeful has published a promising feasibility study. Their stationary storage systems are significantly more profitable than, for example, Tesla's MegaPacks. HelloFresh shareholders have been brought back to reality in recent weeks. After a decline of almost 80% in 6 months, is the share now ripe for a turnaround? Could there even be a takeover?
Read
Commented by Fabian Lorenz on March 20th, 2024 | 07:45 CET
Buying opportunity for HelloFresh and Plug Power? When will the dynaCERT share breakthrough happen?
HelloFresh shares have already lost over 50% of their value in 2024. It should be time for a countermovement, but there is currently no sign of it. One analyst believes the share price could rise by almost 100%. However, he is pretty much alone in this prediction. There are also few optimists at Plug Power at the moment. And from tomorrow, the path to profitability will be a little further away for the hydrogen specialist. In contrast, dynaCERT has been showing relative strength for months. The order intake is decent, and an event should trigger the breakthrough for the share.
Read
Commented by André Will-Laudien on March 19th, 2024 | 06:30 CET
Pay attention now - 100% performance possible with BioNTech, Bayer, Cardiol Therapeutics or HelloFresh
For investors in the biotech sector, 2024 is starting much like the previous year ended. Everyone is waiting for the big bang, which has yet to materialize. However, now that there is no longer a pandemic and cancer research is still stuck in a rut, selection has become crucial. Investing only in the future is no longer a guarantee of profit; instead, it is much more important to identify the most innovative business models and follow them. BioNTech does not currently have a blockbuster but has a good EUR 17 billion in its coffers. Bayer has seen its share price drop fivefold since 2019, and HelloFresh is also unable to keep its promises. By contrast, Cardiol Therapeutics has experienced a true rally. What lies next here?
Read
Commented by Armin Schulz on March 13th, 2024 | 07:30 CET
HelloFresh, Royal Helium, Evotec - Rebounds in sight
Despite all the various challenges in today's world, such as geopolitical tensions or inflation, the stock market indices have managed to climb upwards. Investors are faced with a crucial question: Where is the hidden value in a market that has already broken many records? The answer could lie in those stocks that have so far stood on the sidelines of the great rally - the silent but potentially strong performers waiting for their rebound. This strategy shifts the focus away from the usual suspects who have already posted substantial gains to stocks that are ready to initiate their own rebound, potentially unlocking significant value for patient investors in the process. We have identified three such candidates.
Read